Prof. Dr. med. univ. Dr. med Andreas Beilhack Project B09, B11, Z02
Testbeitrag
Within the Collaborative Research Centre/Transregio (CRC/TRR) 221 innovative immune modulation strategies will be investigated to separate GvHD from GvL effects in order to enhance the safety and efficacy of allo-HSCT in the future.